These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 37479967)

  • 41. Breast Cancer Organoids Model Patient-Specific Response to Drug Treatment.
    Campaner E; Zannini A; Santorsola M; Bonazza D; Bottin C; Cancila V; Tripodo C; Bortul M; Zanconati F; Schoeftner S; Del Sal G
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33371412
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity.
    Bruun J; Kryeziu K; Eide PW; Moosavi SH; Eilertsen IA; Langerud J; Røsok B; Totland MZ; Brunsell TH; Pellinen T; Saarela J; Bergsland CH; Palmer HG; Brudvik KW; Guren T; Dienstmann R; Guren MG; Nesbakken A; Bjørnbeth BA; Sveen A; Lothe RA
    Clin Cancer Res; 2020 Aug; 26(15):4107-4119. PubMed ID: 32299813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patient-Derived Xenograft Models in Breast Cancer Research.
    Na D; Moon HG
    Adv Exp Med Biol; 2021; 1187():283-301. PubMed ID: 33983584
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patient-derived tumor organoids as a platform of precision treatment for malignant brain tumors.
    Chen CC; Li HW; Wang YL; Lee CC; Shen YC; Hsieh CY; Lin HL; Chen XX; Cho DY; Hsieh CL; Guo JH; Wei ST; Wang J; Wang SC
    Sci Rep; 2022 Sep; 12(1):16399. PubMed ID: 36180511
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Patient-derived tumor organoids (or tumoroid) as valuable precision medicine tools].
    Perréard M; Florent R; Thorel L; Vincent A; Weiswald LB; Poulain L
    Med Sci (Paris); 2022 Nov; 38(11):888-895. PubMed ID: 36448894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.
    Qu J; Kalyani FS; Liu L; Cheng T; Chen L
    Cancer Commun (Lond); 2021 Dec; 41(12):1331-1353. PubMed ID: 34713636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. From Cancer to Immune Organoids: Innovative Preclinical Models to Dissect the Crosstalk between Cancer Cells and the Tumor Microenvironment.
    Picca F; Giannotta C; Tao J; Giordanengo L; Munir HMW; Botta V; Merlini A; Mogavero A; Garbo E; Poletto S; Bironzo P; Doronzo G; Novello S; Taulli R; Bersani F
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409152
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing.
    Nanki Y; Chiyoda T; Hirasawa A; Ookubo A; Itoh M; Ueno M; Akahane T; Kameyama K; Yamagami W; Kataoka F; Aoki D
    Sci Rep; 2020 Jul; 10(1):12581. PubMed ID: 32724113
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patient-Derived Triple-Negative Breast Cancer Organoids Provide Robust Model Systems That Recapitulate Tumor Intrinsic Characteristics.
    Bhatia S; Kramer M; Russo S; Naik P; Arun G; Brophy K; Andrews P; Fan C; Perou CM; Preall J; Ha T; Plenker D; Tuveson DA; Rishi A; Wilkinson JE; McCombie WR; Kostroff K; Spector DL
    Cancer Res; 2022 Apr; 82(7):1174-1192. PubMed ID: 35180770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patient-derived Organoids in Bladder Cancer: Opportunities and Challenges.
    Radić M; Egger M; Kruithof-de Julio M; Seiler R
    Eur Urol Focus; 2024 Sep; ():. PubMed ID: 39232905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
    Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
    J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays.
    van Biljon L; Fashemi B; Rodriguez J; Graham O; Compadre A; Fuh K; Khabele D; Mullen M
    J Vis Exp; 2023 Feb; (192):. PubMed ID: 36912550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Budget-Friendly Generation, Biochemical Analyses, and Lentiviral Transduction of Patient-Derived Colon Organoids.
    Rigaux E; Chen JW; George F; Lemaire J; Bertrand C; Faugeras L; Fattaccioli A; Gilliaux Q; D'Hondt L; Michiels C; Renard HF; Zanin N
    Curr Protoc; 2023 Dec; 3(12):e943. PubMed ID: 38058263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesis.
    Yucer N; Ahdoot R; Workman MJ; Laperle AH; Recouvreux MS; Kurowski K; Naboulsi DJ; Liang V; Qu Y; Plummer JT; Gayther SA; Orsulic S; Karlan BY; Svendsen CN
    Cell Rep; 2021 Dec; 37(13):110146. PubMed ID: 34965417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Establishment of Human Pituitary Neuroendocrine Tumor Derived Organoid and Its Pilot Application for Drug Screening.
    Cui R; Duan H; Hu W; Li C; Zhong S; Liang L; Chen S; Hu H; He Z; Wang Z; Guo X; Chen Z; Xu C; Zhu Y; Chen Y; Sai K; Yang Q; Guo C; Mou Y; Jiang X
    J Clin Endocrinol Metab; 2024 Apr; ():. PubMed ID: 38656317
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids.
    Shirure VS; Bi Y; Curtis MB; Lezia A; Goedegebuure MM; Goedegebuure SP; Aft R; Fields RC; George SC
    Lab Chip; 2018 Dec; 18(23):3687-3702. PubMed ID: 30393802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune organoids: from tumor modeling to precision oncology.
    Dao V; Yuki K; Lo YH; Nakano M; Kuo CJ
    Trends Cancer; 2022 Oct; 8(10):870-880. PubMed ID: 35773148
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Application and research progress of patient-derived organoids in the multimodality treatment of pancreatic cancer].
    Wang HW; Ma XQ; Gao S; Hao JH
    Zhonghua Wai Ke Za Zhi; 2024 Jul; 62(7):710-713. PubMed ID: 38808439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity.
    Kopper O; de Witte CJ; Lõhmussaar K; Valle-Inclan JE; Hami N; Kester L; Balgobind AV; Korving J; Proost N; Begthel H; van Wijk LM; Revilla SA; Theeuwsen R; van de Ven M; van Roosmalen MJ; Ponsioen B; Ho VWH; Neel BG; Bosse T; Gaarenstroom KN; Vrieling H; Vreeswijk MPG; van Diest PJ; Witteveen PO; Jonges T; Bos JL; van Oudenaarden A; Zweemer RP; Snippert HJG; Kloosterman WP; Clevers H
    Nat Med; 2019 May; 25(5):838-849. PubMed ID: 31011202
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors.
    Maru Y; Tanaka N; Itami M; Hippo Y
    Gynecol Oncol; 2019 Jul; 154(1):189-198. PubMed ID: 31101504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.